Skip to main content
SpringerLink
Log in

The Future for Surfactant Therapy of the Adult Respiratory Distress Syndrome

  • Conference paper
Surfactant Replacement Therapy

Abstract

Few clinical syndromes are as frustrating to the critical care specialist as the adult respiratory distress syndrome (ARDS). Its pathogenesis is frequently obscure. Current therapy is entirely supportive. The clinical course is unpredictable. Interventional strategies, often initially promising, have proven disappointing. Finally, the high mortality rate has not been demonstrably improved despite several decades of effort.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Ashbaugh DG, Bigelow DB, Petty TL (1967) Acute respiratory distress in adults. Lancet II: 319–323

    Article  Google Scholar 

  2. Unger KM, Shibel EM, Moser KM (1975) Detection of left ventricular failure in adult respiratory distress syndrome. Chest 67: 8–13

    Article  PubMed  CAS  Google Scholar 

  3. Hopewell PC, Murray JF (1982) Adult respiratory distress syndrome. In: Moser KM, Spragg RG (eds) In respiratory emergencies. CV Mosby, St Louis, pp 94–122

    Google Scholar 

  4. Schlag G, Voigt WH, Redl H, Glatzl A (1980) Vergleichende Morphologie des posttraumatischen Lungenversagens. Anasth Intensivther Notfallmed 15: 315–339

    Article  PubMed  CAS  Google Scholar 

  5. Bachofen M, Weibel ER (1982) Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 3: 35–56

    PubMed  CAS  Google Scholar 

  6. Pratt PC, Vollmer RT, Shelburne JD, Crapo JD (1979) Pulmonary morphology in a multihospital collaborative extracorporeal membrane oxygenator project. Am J Pathol 95: 191–214

    PubMed  CAS  Google Scholar 

  7. Christner P, Fein A, Goldberg S, Lippman M, Abrams W, Weinbaum G (1985) Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome. Am Rev Respir Dis 131: 690–695

    PubMed  CAS  Google Scholar 

  8. McGuire WW, Spragg RG, Cohen AB, Cochrane CG (1980) Studies on the pathogenesis of the adult respiratory distress syndrome I. J Clin Invest 69: 543–553

    Article  Google Scholar 

  9. Lee CT, Fein AM, Lippman ML, Holtzman H, Kimbel P, Weinbaum G (1981) Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory distress syndrome. N Engl J Med 304: 192–196

    Article  PubMed  CAS  Google Scholar 

  10. Cochrane CG, Spragg RG, Revak S (1983) Studies of the pathogenesis of the adult respiratory distress syndrome: evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest 71: 754–761

    Article  PubMed  CAS  Google Scholar 

  11. Kellog EW, Fridovich I (1977) Liposome oxidation and erythrocyte lysis by enzymatically generated syperoxide and hydrogen peroxide. J Biol Chem 752: 6721–6728

    Google Scholar 

  12. Schraufstatter IU, Hinshaw DB, Spragg RG, Cochrane CG (1986) Oxidant injury of cells: DNA strand breaks activate poly-ADP-ribose polymerase and leads to depletion of nicotinamide adenine dinucleotide. J Clin Invest 77: 1312–1320

    Article  PubMed  CAS  Google Scholar 

  13. Baldwin SR, Simon RH, Grum CM, Ketai LH, Boxer LA, Devall LJ (1986) Oxidative activity in expired breath of patients with adult respiratory distress syndrome. Lancet I: 11–14

    Article  Google Scholar 

  14. Sznajder JI, Fraiman A, Crawford G, Hall J, Schmidt G, Sanders W, Wood LDH (1987) Increased oxidant activity in expiratory breath of patients with hypoxemic respiratory failure. Am Rev Respir Dis 135: A264

    Google Scholar 

  15. Janoff A, George-Nascimento C, Rosenberg S (1986) A genetically engineered, mutant human alpha-1-proteinase inhibitor is more resistant than the normal inhibitor to oxidative inactivation by chemicals, enzymes, cells, and cigarette smoke. Am Rev Respir Dis 133: 353–356

    PubMed  CAS  Google Scholar 

  16. Abrams WR, Fein AM, Kucich U, Kueppers F, Yamiada H, Kozmorycz T, Morgan L, Lippmann M, Goldberg SK, Weinbaum G (1984) Proteinase inhibitory function in inflammatory lung disease. Am Rev Respir Dis 129: 735–741

    PubMed  CAS  Google Scholar 

  17. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, Edwards DK III, Gluck L (1983) Elastase and alpha-1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 72: 656–666

    Article  PubMed  CAS  Google Scholar 

  18. Petty TL, Reiss OK, Paul GW, Silvers GW, Elkins ND (1977) Characteristics of pulmonary surfactant in adult respiratory distress syndrome associated with trauma and shock. Am Rev Respir Dis 115: 531–536

    PubMed  CAS  Google Scholar 

  19. Von Wichert P, Kohl FV (1977) Decrease dipalmitoyllecithin content found in lung specimens from patients with so-called shock-lung. Eur J Intensiv Care 3: 27–30

    Article  CAS  Google Scholar 

  20. Hallman M, Spragg RG, Harrell JH, Moser KM, Gluck L (1982) Evidence of lung surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, surface activity and plasma myoinosotol. J Clin Invest 72: 656–666

    Google Scholar 

  21. Rauvala H, Hallman M (1984) Glycolipid accumulation in bronchoalveolar space in adult respiratory distress syndrome. J Lipid Res 25: 1257–1262

    PubMed  CAS  Google Scholar 

  22. Holm BA, Notter RH, Finkelstein JN (1985) Surface property changes from interactions of albumin with natural lung surfactant and extracted lung lipids. Chem Phys Lipids 38: 287–298

    Article  PubMed  CAS  Google Scholar 

  23. Holm BA, Notter RH (1987) Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol 63: 1434–1442

    PubMed  CAS  Google Scholar 

  24. Seeger WG, Stohr G, Wolf HRD, Neuhof H (1985) Alteration of surfactant function due to protein leakage: special interaction with fibrin monomer. J Appl Physiol 58: 326–338

    PubMed  CAS  Google Scholar 

  25. Fuchimukai T, Fujiwara T, Takahashi A, Enhorning G (1987) Artificial pulmonary surfactant inhibited by proteins. J Appl Physiol 62: 429

    Article  PubMed  CAS  Google Scholar 

  26. Merritt TA, Revak S, Hallman M (1987) Elastolytic degradation of surfactant 35kD apoprotein. Pediatr Res 21: 460A

    Google Scholar 

  27. Nieman GF, Bredenberg CE (1985) High surface tension pulmonary edema induced by detergent aerosol. J Appl Physiol 58: 129–136

    PubMed  CAS  Google Scholar 

  28. Bredenberg CE, Nieman GF, Paskanik AM, Hart KE (1986) Microvascular membrane permeability in high surface tension edema. J Appl Physio1 60: 253–259

    CAS  Google Scholar 

  29. Richman P, Batcher S, Catanzaro (1986) Immunoregulation by pulmonary surfactant in vitro. Am Rev Respir Dis 133: A312

    Google Scholar 

  30. Ansfield MJ, Benson BJ, Kaltreider HB (1979) Immunosuppression by surface active material: lack of species specificity. Am Rev Respir Dis 120: 949–952

    PubMed  CAS  Google Scholar 

  31. LaForce FM, Kelly WJ, Huber GL (1977) Inactivation of staphlococci by alveolar macrophages with pulmonary observations on the importance of alveolar lining material. Am Rev Respir Dis 108: 784–790

    Google Scholar 

  32. Jonsson S, Musher DM, Goree A, Lawrence EC (1986) Human alveolar lining material and antibacterial defenses. Am Rev Respir Dis 133: 136–140

    PubMed  CAS  Google Scholar 

  33. Bernard GR, Harris TR, Luce JE, Rinaldo JE, Sibbald WJ, Sprung CL, Tate RM, Higgins S, Kariman K, Bradley R, Brigham KL (1987) The effects of high dose methyl prednisolone in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 125: A5

    Google Scholar 

  34. Luce JM, Marks JD, Montgomery AB, Turner J, Metz CA, Murray JE (1987) Methyl prednisolone does not prevent the adult respiratory distress syndrome or more mortality in patients with septic shock. Am Rev Respir Dis 135: A5

    Google Scholar 

  35. Russell JA (1987) Prostoglandin E1 does not alter mortality of adult respiratory distress syndrome. Chest 92: 59S

    Google Scholar 

  36. Wright JR, Clements JA (1987) Metabolism and turnover of lung surfactant. Am Rev Respir Dis 136: 426–444

    Article  PubMed  CAS  Google Scholar 

  37. Lachmann B (1987) The role of pulmonary surfactant in the pathogenesis and therapy of ARDS. In: Vincent JL (ed) Update in intensive care and emergency medicine. Springer, Berlin Heidelberg New York, pp 123–134

    Google Scholar 

  38. Richman PS, Spragg RG, Merritt TA, Robertson B, Curstedt T (1987) Administration of porcine-lung surfactant to humans with ARDS: initial experience. Am Rev Respir Dis 135: A5

    Google Scholar 

Download references

Authors
  1. R. G. Spragg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Richman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Gilliard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. A. Merritt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, Erasmus University, Postbox 1738, NL-3000 DR, Rotterdam, The Netherlands

    Burkhard Lachmann MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Spragg, R.G., Richman, P., Gilliard, N., Merritt, T.A. (1988). The Future for Surfactant Therapy of the Adult Respiratory Distress Syndrome. In: Lachmann, B. (eds) Surfactant Replacement Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73305-5_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73305-5_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73307-9

  • Online ISBN: 978-3-642-73305-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation